-
Mashup Score: 2Low level of regret for treatment decision for most adults with low-risk thyroid cancer - 8 month(s) ago
Adults with low-risk papillary thyroid cancer reported low levels of decision regret for their disease management choice at 1 year, regardless of whether they chose active surveillance or surgery, according to findings published in Thyroid. In a prospective observational study from a single health system in Canada, levels of decision regret as determined through the Decision Regret Scale were
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 2Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults - 8 month(s) ago
Nature Reviews Endocrinology – Applying a uniform reference range across all adults for serum levels of thyroid stimulating hormone and thyroid hormones makes establishing a diagnosis of thyroid…
Source: www.nature.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 3Major adverse CV event risk lower after surgery, radioactive iodine for hyperthyroidism - 9 month(s) ago
Adults with hyperthyroidism who undergo surgery or receive radioactive iodine therapy have a lower risk for major adverse cardiovascular events than those receiving antithyroid drugs, according to data published in JAMA Network Open. “We found that over a mean follow-up of 4.4 years, hyperthyroid patients treated with surgery had a 47% lower risk of death and a 24% lower risk of major
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 13Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults - 9 month(s) ago
Nature Reviews Endocrinology – Applying a uniform reference range across all adults for serum levels of thyroid stimulating hormone and thyroid hormones makes establishing a diagnosis of thyroid…
Source: www.nature.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1Do Organophosphate Esters Increase Thyroid Disease Risk? - 9 month(s) ago
Chemicals found in flame retardants were linked to increased risk for thyroid disease, study finds.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 9Medullary thyroid carcinoma: a narrative historical review - 9 month(s) ago
Sporadic or hereditary medullary thyroid carcinoma (MTC) is an uncommon thyroid malignancy arising from calcitonin secreting parafollicular C cells. Interestingly, MTC and calcitonin were distinct …
Source: www.tandfonline.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 3VIDEO: New thyroid dysfunction presenting postpartum can be easy to miss - 10 month(s) ago
In this video exclusive, Nicole Gomez, MD, talks with Caroline T. Nguyen, MD, about diagnosing and managing thyroid dysfunction in the postpartum period.Gomez is assistant professor of obstetrics and gynecology in the division of maternal and fetal medicine at the Keck School of Medicine of the University of Southern California. Nguyen is assistant professor of clinical medicine, obstetrics and
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 12Predicting Differentiated Thyroid Cancer Outcomes Using Machine Learning: A Move toward Precision Medicine | Clinical Thyroidology® - 10 month(s) ago
Clinical Thyroidology®
Source: www.liebertpub.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1
Just over a century ago, much of the U.S. population experienced disfiguring and debilitating disorders related to iodine deficiency. In 2024, we celebrate 100 years of salt iodization — a tremendous public health achievement.Soils across much of the upper Midwest and Pacific Northwest and throughout the Appalachians are poor in iodine, which resulted in iodine-deficient diets for humans
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Hearing loss with teprotumumab more likely for adults with baseline hearing dysfunction - 10 month(s) ago
Hearing loss occurred more frequently among adults who received teprotumumab for the treatment of thyroid eye disease if they had impaired hearing at the start of therapy, according to a research letter published in Thyroid. In a small prospective cohort study, one adult out of 32 (3%) with normal hearing at baseline developed hearing decline after a full, 24-week course of teprotumumab-trbw
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
📰Adults with low-risk papillary #thyroid cancer tend to not regret their initial treatment decision, regardless of if they undergo surgery or opt for active surveillance. Read more 👇 @UofT_DoM @PMResearchUHN @UHN_Supportive @PMCancerRehab https://t.co/olXw0yFKWp